ITeos Therapeutics Inc (NASDAQ: ITOS) – Not A Clear Buying Opportunity?

ITeos Therapeutics Inc (ITOS) concluded trading on Thursday at a closing price of $13.64, with 0.49 million shares of worth about $6.68 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 18.51% during that period and on March 28, 2024 the price saw a gain of about 3.57%. Currently the company’s common shares owned by public are about 35.84M shares, out of which, 28.53M shares are available for trading.

Stock saw a price change of 19.65% in past 5 days and over the past one month there was a price change of 26.53%. Year-to-date (YTD), ITOS shares are showing a performance of 24.57% which decreased to -2.15% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $8.20 but also hit the highest price of $18.24 during that period. The average intraday trading volume for ITeos Therapeutics Inc shares is 263.90K. The stock is currently trading 19.69% above its 20-day simple moving average (SMA20), while that difference is up 26.36% for SMA50 and it goes to 19.96% higher than SMA200.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


ITeos Therapeutics Inc (NASDAQ: ITOS) currently have 35.84M outstanding shares and institutions hold larger chunk of about 81.29% of that.

The stock has a current market capitalization of $488.86M and its 3Y-monthly beta is at 1.18. It has posted earnings per share of -$3.15 in the same period. It has Quick Ratio of 13.76 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ITOS, volatility over the week remained 5.38% while standing at 5.33% over the month.

Analysts are in expectations that ITeos Therapeutics Inc (ITOS) stock would likely to be making an EPS of -$1.26 in the current quarter, while forecast for next quarter EPS is -$1.24 and it is -$6.19 for next year. For the current quarter EPS, analysts have given the company a lowest target -$2.2 which is -$0.86 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.44 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -46.75% while it is estimated to decrease by -29.55% in next year.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on May 05, 2021 offering a Buy rating for the stock and assigned a target price of $37 to it. Coverage by Robert W. Baird stated ITeos Therapeutics Inc (ITOS) stock as an Outperform in their note to investors on October 08, 2020, suggesting a price target of $45 for the stock. On August 18, 2020, Wedbush Initiated their recommendations, while on August 18, 2020, SVB Leerink Initiated their ratings for the stock with a price target of $45. Stock get an Overweight rating from Piper Sandler on August 18, 2020.

Most Popular

Related Posts